Rumiana Tenchov

Information Scientist, CAS

Bio

Rumiana Tenchov is an information scientist at CAS. She earned her Ph.D. and D.Sc. degrees in biophysics from the Bulgarian Academy of Sciences. Prior to joining CAS, she was a research faculty member at the Department of Molecular Biosciences of the Northwestern University.

Drug Discovery
Nanoscale drug delivery systems can improve treatment for cancer, autoimmune diseases, HIV, and other conditions
|Article
Drug Discovery
薬剤リポジショニング、細胞療法、遺伝子療法を含む併用療法が、いかに希少疾患の治療改善につながっているか。
|Article
Biotechnology
Parkinson's disease can be distressing for families, so scientists are working hard to find potential treatments by repurposing drugs and more.
|Article
Emerging Science
Uncover the latest advancements in understanding and treating neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s.
|Insights Report
Drug Discovery
Sharing new research on inverse vaccines, potential new breakthroughs in treating autoimmune diseases like multiple sclerosis, type 1 diabetes and celiac disease
|Article
Drug Discovery
Biomarkers, personalized medicine and gene therapies are fueling research breakthroughs. Discover new treatments targeting genetics and protein buildup to manage this devastating disease.
|Article
Drug Discovery
While no cure exists for PolyQ diseases like Huntington's, new breakthroughs, therapies, and research could change that.
|Article
Biotechnology
As cancer is projected to increase, finding stronger therapeutics is more urgent. Biomarkers offer a potential solution for better diagnosis and treatment.
|Article
Emerging Science
CAS and Excelra delved into data surrounding biomarkers and their relationship to cancer to identify key targets for future study.
|Insights Report
Drug Discovery
Since 2018, research interest in antibody-drug conjugates has increased exponentially, due to their potential in the fight against cancer.
|Article
Emerging Science
Discover the latest in anti-aging treatment strategies to promote health and longevity, including stem cell therapies, hyaluronic acid, senolytics, gene therapy, and more.
|Article
Emerging Science
PEG immunogenicity affects the safety and efficacy of PEGylated lipid nanoparticles for drug delivery. Much work is being done to circumvent this challenge in applying these polymers.
|Article
Emerging Science
The gut microbiome is a complex ecosystem of trillions of bacteria that live in our digestive tracts with health benefits like immunity, improved mental health, and therapeutic options.
|Article
Biotechnology
A historical overview of the discovery of exosomes, key milestones in their rise, and why they will revolutionize the diagnostic and drug delivery fields in the future.
|Article
Safety
Ammonium nitrate has the power to feed billions, yet when stored improperly is like a bomb waiting to happen. How can we make this fertilizer safer? Learn about emerging science, safer alternatives, and best practices for safe storage and transport.
|Article
Drug Discovery
Explore lipid nanoparticles: from origins to COVID vaccines and beyond. Discover emerging trends in publications and milestones. Uncover future applications in vaccines, drug delivery, and non-therapeutic fields like agro-chemistry, cosmetics, and food science. Learn how these particles are shaping
|Article
Drug Discovery
The COVID pandemic revealed deficiencies in mask development and production. Innovation will be crucial in slowing the spread of new variants of the virus.
|Article
Drug Discovery
Learn about the important functions of intrinsically disordered proteins and the key role they play in COVID-19 therapy.
|Article
Emerging Science
Gut microbiota, gut flora, or microbiome are the microorganisms that live in the digestive tracts of humans and other animals. While some bacteria are associated with disease, others are particularly important for many aspects of health and mental health.
|Article
Biotechnology
Learn more about the applications of lipid nanoparticles in cancer therapy, their therapeutic benefits, and their future within nanomedicine.
|Article
Emerging Science
Newly developed microfluidic fabrication technology addresses the clinical need for scalable, precise, and reproducible solutions for vaccine production.
|Article
Sustainability
An overview of research on how microbial enzymes can break down plastics, which could otherwise take hundreds of years to degrade.
|Article